Extrachromosomal circular DNA has emerged as a pivotal factor in tumor biology, contributing to intratumor heterogeneity, oncogene amplification, and tumor
1 October 2024 in Nanomedicine: Nanotechnology, Biology and Medicine
Maintenance therapy (MT) for ovarian cancer (OC) is crucial for preventing disease relapse. Curcumol shows effective anti-OC ability and low-toxicity to the normal ovarian epithelial cells, however, its bioavailability is low. Herein, micellar loaded curcumol (MC) was prepared and the anti-tumor ability of MC were performed on OC cells. The results indicated that the IC50 values of MC in two kinds of OC cells were 37.69 +/- 2.43 and 28.54 +/- 1.58 mu g/mL, respectively. Mechanistically, curcumol could interact with the AKTThr308 site, inhibiting the phosphorylation of FOXO3a, which promoted FOXO3a nuclear locating and recruited it to the PERK promoter, activating the ERS induced apoptosis pathway. Moreover, MC inhibited the growth of SKOV3 cells on tumorbearing nude mice and the DiR-labeled MC could quickly accumulate in the tumor region. MC provides great feasibility to achieve efficient MT for OC based on the nanoplatforms of active ingredients from natural products.
A caesarean scar niche, particularly a large niche, is associated with important long-term gynaecological and reproductive complications. Although the neon
Background: Maintenance therapy (MT) after postoperative platinum-based chemotherapy for ovarian cancer (OC) is crucial for delaying or preventing disease relapse. The current targeted drugs are only effective in about 30% of OC patients and the options for MT are limited. FOXO3a was considered as a potential target of chemotherapeutic drugs for OC due to its key role in inhibiting disease progression and recurrence. Curcumol, a major constituent of the plant Rhizoma Curcumae, is a low-toxic and effective anti-cancer drug which indicates that it is a potential candidate for MT. However, curcumol is indissolubility in water, with low bioavailability, and its pharmacological basis is unclear. Herein, Micellar curcumol (MC) was prepared for the therapy of OC. Parallel assessments of the anti-tumor ability and mechanism of MC were performed on two kinds of OC cells. Results: The results indicated that the IC50 of MC in two OC cells were as low as 37.69±2.43 and 28.54±1.58 μg/mL, respectively. Curcumol, by inhibiting phosphorylation at the AKTT308 site, activates the transcriptional activity of FOXO3a, which further promotes the recruitment of FOXO3a to the promoter sequence of endoplasmic reticulum stress-related PERK genes, inducing OC cells apoptosis. Moreover, the DiR-labeled MC could quickly accumulate in the tumor region within only 1h and maintain for 48 h in vivo. Further, MC inhibited the growth of SKOV3 cells on tumor-bearing nude mice by intravenous injection. Conclusions: Micellar loaded curcumol provides great feasibility to achieve efficient MT for OC based on the nanoplatforms of active ingredients from natural products.